MYGN compared with IRWD: revenue, margins and what each company keeps, and the suppliers and customers both name

MYGNMyriad Genetics Inc

Mkt capRevenueRevenue

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

MYGNMyriad Genetics Inc

IRWDIronwood Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MYGN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±17.6%▲+4.49%×0.26

Q2 FY26±20.0%▼−46.74%×2.33

Q1 FY26±20.1%▼−18.29%×0.91

Feb 24 '26±61.3%▲+1.14%×0.02

IRWD

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±31.0%▲+6.90%×0.22

Q2 FY26±15.6%▲+2.65%×0.17

= impliedMYGN realized, solidIRWD realized, hatchedOne scale, both sides: full bar = 62%× = |realized| ÷ impliedSource: market data

May 7 '26

±11.8%

▼−13.66%

×1.16

Q1 FY26±22.4%▼−11.35%×0.50

MYGNMyriad Genetics Inc

5.94▼−5.56%· post 5.89

Mkt cap$567.9MRevenue$203MQ3 FY26Revenue$825MFY25

IRWDIronwood Pharmaceuticals Inc

4.37▲+8.35%· post 4.30

ClosedNov 6 '26

Mkt cap$726.8MRevenue$133MQ3 FY26Revenue$296MFY25

Compare

ClosedNov 6 '26

MYGNMyriad Genetics Inc

IRWDIronwood Pharmaceuticals Inc

5.94▼−5.56%post 5.89

Price

4.37▲+8.35%post 4.30

$567.9M

Mkt cap

$726.8M

Q3 FY26$203M

Revenue

$133MQ3 FY26

FY25$825M

Revenue

$296MFY25

MYGN5.94▼−5.56%vsIRWD4.37▲+8.35%ClosedNov 6 '26